D.E. Shaw & Co
AMPE

D.E. Shaw & Co’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

D.E. Shaw & Co’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-405
Closed -$20K – 5751
2022
Q2 		$20K Buy
405
+235
+138% +$17.5K ﹤0.01% 5023
2022
Q1 		$24K Sell
170
-3,713
-96% -$542K ﹤0.01% 5307
2021
Q4 		$664K Buy
3,883
+2,488
+178% +$928K ﹤0.01% 4229
2021
Q3 		$695K Buy
1,395
+1,223
+711% +$567K ﹤0.01% 3872
2021
Q2 		$86K Buy
+172
New +$92.4K ﹤0.01% 4574
2016
Q2 		– Sell
-195
Closed -$132K – 3600
2016
Q1 		$132K Buy
195
+5
+3% +$3.37K ﹤0.01% 3250
2015
Q4 		$199K Sell
190
-12
-6% -$11.9K ﹤0.01% 3562
2015
Q3 		$175K Sell
202
-203
-50% -$170K ﹤0.01% 3528
2015
Q2 		$288K Buy
405
+82
+25% +$87.4K ﹤0.01% 3435
2015
Q1 		$730K Buy
323
+25
+8% +$42.6K ﹤0.01% 2794
2014
Q4 		$306K Buy
298
+198
+198% +$212K ﹤0.01% 3633
2014
Q3 		$106K Buy
100
+18
+22% +$30.3K ﹤0.01% 3977
2014
Q2 		$206K Sell
82
-383
-82% -$782K ﹤0.01% 3975
2014
Q1 		$885K Buy
+465
New +$1.1M ﹤0.01% 3142
2013
Q4 		– Sell
-48
Closed -$107K – 4766
2013
Q3 		$107K Buy
+48
New +$92.8K ﹤0.01% 4182

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

D.E. Shaw & Co's AMPE Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 405 shares — an estimated $20K sold.

D.E. Shaw & Co first reported a position in AMPE in Q3 2013 and held it in 15 quarters. The position peaked at $885K in Q1 2014. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 405 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $20K.
  • D.E. Shaw & Co first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Ampio Pharmaceuticals Inc. position peaked at $885K in Q1 2014.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.